Skip to main content
BMC Psychiatry logoLink to BMC Psychiatry
. 2024 Jun 20;24:463. doi: 10.1186/s12888-024-05908-8

Psychoeducational group interventions for adults diagnosed with attention-deficit/ hyperactivity disorder: a scoping review of feasibility, acceptability, and outcome measures

Tatiana Skliarova 1,, Henrik Pedersen 1,2, Åshild Holsbrekken 2, Sindre Andre Pedersen 3, Arthur Mandal 4, Carlos De Las Cuevas 5, Audun Havnen 3,6, Rolf Gråwe 1,7, Mariela Loreto Lara-Cabrera 1,8
PMCID: PMC11191191  PMID: 38902683

Abstract

Introduction

Although psychoeducational group interventions are increasingly used for adults diagnosed with attention-deficit/hyperactivity disorder (ADHD), a comprehensive review focused on the feasibility and acceptability indicators of these interventions remains lacking. Furthermore, although previous research has explored various aspects of psychoeducation for ADHD, such as its definition and approaches, limited research has focused on the synthesis for outcome measures and patients’ experiences related to these interventions. Therefore, this scoping review aims to map the existing evidence reported on psychoeducational group interventions for adults diagnosed with ADHD. The objective is to provide a comprehensive overview of feasibility indicators, acceptability, and outcome measures used in psychoeducational group interventions.

Method

A comprehensive structured literature search on the topic was performed in seven bibliographic databases, and the resulting records were independently screened, and their data extracted by two reviewers. We followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-S) to ensure the transparency and rigor of this scoping review.

Results

The searches yielded 7510 records. Eight studies met the inclusion criteria. These included studies were conducted in European countries and the United States. Among these, six studies used a randomized control design, one an open feasibility trial, and one a pre-post intervention design. All the studies reported some feasibility and acceptability indicators. While all the studies reported on the severity of symptoms of ADHD as an outcome measure, some also reported on outcomes related to psychological or mental-health problems, quality of life, changes in knowledge regarding ADHD, or the level of self-esteem, functioning, and impairment.

Conclusion

This scoping review revealed that psychoeducational group interventions are generally acceptable for patients in terms of patient satisfaction with the group intervention. All included studies reported some feasibility indicators, with some reporting good attendance and relatively low dropout rates. Most studies reported positive effects on ADHD and mental health symptoms, suggesting that these interventions are beneficial for adults with ADHD. However, several gaps exist regarding the reporting on the feasibility indicators, acceptability, and outcome measures employed across studies.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12888-024-05908-8.

Keywords: Attention-deficit/hyperactivity disorder (ADHD), Feasibility, Patient education, Patient satisfaction, Psychoeducational intervention, Patient-reported outcomes (PROM), Scoping review

Background

Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition primarily characterized by long-term difficulties with symptoms of inattention, impulsivity, and hyperactivity [1, 2]. While ADHD is often recognized and diagnosed during childhood, its effects frequently extend into adulthood [3]. Furthermore, ADHD remains a significant concern in the adult population, with approximately 2.5% of adults worldwide estimated to be affected by this disorder [4]. In addition to presenting persistent challenges related to core symptoms, including hyperactivity, inattentiveness, and impulsivity, ADHD frequently co-occurs with other mental disorders [59] and is linked to difficulties in occupational performance [1013]. These challenges can significantly affect working ability, psychosocial function, and educational achievement [12, 13]. Furthermore, adults with ADHD also report a diminished quality of life [14], substantial stigmatization [15], and fewer psychological protective factors, including self-management skills [16, 17]. For adults with ADHD, recent research and the current international clinical guidelines [18, 19] recommend a range of treatments encompassing pharmacological and nonpharmacological approaches [2022]. Nonpharmacological approaches include psychosocial and educational strategies [20, 22, 23].

Psychoeducational interventions aim to improve patient attitudes (reflecting their perception of responsibility for their disease) and how they cope with their illness [24]. In psychiatric research, psychoeducation has gained recognition as a valuable adjunctive treatment for schizophrenia [25], psychosis risk [26], bipolar disorder [27], depression [28], and anxiety [29], and as a beneficial aid for caregivers and teachers of children with ADHD [30]. Psychoeducational group interventions have become increasingly important in managing chronic disorders [31]. Such interventions aim to provide information about the condition to adults newly diagnosed with mental disorders and offer crucial support. The primary focus of these interventions is to help patients learn and develop the skills necessary to independently manage their condition, adapt to, and live with their mental-health problems [32].

Recent studies have found that individuals diagnosed with ADHD want to learn more about various aspects of their diagnoses [3336]. Psychoeducational programs enable individuals to acquire knowledge and gain a better understanding of their disorder and its associated challenges [37]. By delivering relevant information, these educational programs may also facilitate patients’ to accept their condition and alleviate negative emotions [37]. While individual psychoeducation is well implemented in clinical settings, in group-based interventions, the potential exists for further improvement in the delivery of information for adults newly diagnosed with ADHD. From user and mental healthcare perspectives, group-based intervention represents one method to provide information through shared learning [38]. In contrast to giving participants information individually, in a group setting, patients can learn from each other’s questions and coping strategies related to their condition. Furthermore, group-based psychoeducation makes peer support possible, and allows delivering comprehensive information and supporting more patients. Additionally, group-based interventions can appear to be promising, efficient interventions if they are feasible for mental healthcare services to deliver. Moreover, given that most psychoeducational programs in the field of mental health are complex group-based approaches [3841], special attention should be focused on the acceptability of such programs.

Research on psychoeducational group interventions for adults with ADHD is still in its early stages, with no reviews focusing specifically on group-based interventions. A review conducted in 2016 [42], however, included three studies, of these only two focused on group-based approaches [43, 44]. Subsequently, a more detailed scoping review [45] was undertaken with a broader scope of identifying the characteristics of psychoeducational interventions tailored for adults with ADHD. This scoping review explored the various definitions and conceptualizations of “psychoeducation” within the context of these interventions. This later scoping review included a total of 10 articles published in English that specifically addressed psychoeducation for adults with ADHD [45]. Although the authors highlighted psychoeducational group interventions as a new approach to informing and educating adults diagnosed with ADHD, the review did not examine any feasibility or acceptability indicators for the intervention. Furthermore, although prior research has addressed various aspects of group-based approaches, the synthesis of the parameters used for outcome measures and patients’ experiences related to psychoeducational group interventions tailored to adults is limited. Some authors have claimed that patient-reported outcome measures (PROMs) are critical for promoting patient-centered care and evaluating patients’ views on their mental health, well-being, and functional status [46]. In addition, PROMs are included in clinical trials as indicators of the effectiveness of interventions, and they inform clinical practice and stakeholders about opportunities to improve the quality of mental-health treatment.

Given the nature of group-based psychoeducation and the limited number of studies reported in recent research [45], we conducted a scoping review [47, 48]. This study aims to map the existing evidence reported on psychoeducational groups interventions for adults diagnosed with ADHD. The objective is to provide a comprehensive overview of feasibility indicators, acceptability, and outcome measures used in psychoeducational group interventions, providing insight to researchers, clinicians, user organizations, and policymakers involved in group treatment and the informational support of these adults.

Methods

Our study was conducted according to the recommended methodology guidelines for scoping reviews [47] and conforms with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) [49] and the frameworks for reporting the feasibility [50] and acceptability of health interventions [51].

Our review process commenced with the definition of objectives and the formulation of three clear and focused research questions to guide the review, in collaboration with user representatives from ADHD organizations. These questions aimed to identify and describe the feasibility and acceptability, as well outcome measures used in psychoeducational group interventions for adults diagnosed with ADHD. Additionally, we consulted with one user representative (AM) working in the field of ADHD and one (HH) working in the field of psychoeducation. User representatives helped define the objectives, develop the inclusion criteria, and ensure the accuracy and comprehensiveness of our review findings.

Searches, eligibility criteria, and study selection

A medical research librarian (SAP) developed a rigorous search strategy. The search consisted of the three concepts “psychoeducation”, “ADHD” and “adults”. Relevant thesaurus terms and free text terms were searched within each concept and combined using the operator “OR”. Finally, all three concepts were combined using the operator “AND”.

The structured search strategy was conducted by a medical research librarian (SAP) and adapted to and run across the bibliographic databases MEDLINE, Embase, Web of Science, Cochrane Central, CINAHL, AMED, PsycINFO, and the register ClinicalTrials.gov. The search was last updated in all the databases on January 5, 2024, apart from PsycINFO, which was unavailable on that date and therefore last updated on June 7, 2022. The search interface for MEDLINE and Embase also changed from Ovid to EBSCOhost and Embase.com, respectively, in their last updates. Records captured in the literature search were imported into Endnote 20 reference management software, and duplicates were subsequently removed. Additional File 1 provides the detailed search strategy adopted for the various databases.

The inclusion criteria encompassed peer-reviewed studies that reported findings from a psychoeducational group intervention program involving adults. Eligible studies included pilot studies, clinical studies, feasibility studies, and randomized controlled trials (RCTs). A study was considered for inclusion if it investigated the psychoeducational group intervention alone, in comparison to another treatment, or as a control group. The authors (TS, HP, AH, ÅH, and MLL-C) conducted a duplicate screening of titles and abstracts, including all articles that used the terms “ADHD” or “hyperkinetic disorder” and “psychoeducation” or “patient education”. Additionally, only studies with “adults” or “adulthood” mentioned in their title or abstract were included. The exclusion criteria encompassed studies that do not address the main research question or focus on non-psychoeducational interventions. In addition, grey literature, non-peer-reviewed articles, conference abstracts, protocols and theoretical articles were excluded. The study selection process is illustrated in the PRISMA flow diagram (Fig. 1).

Fig. 1.

Fig. 1

PRISMA flow diagram. Note: PE = Psychoeducation

Data extraction and analysis

The data charting process used predefined tables, allowing us to extract, organize, and categorize the relevant information. Critical information related to the study characteristics, participant demographics, and intervention details was extracted independently by authors (TS, HP, RG, CdLC, and ÅH). Feasibility can be assessed using different feasibility indicators, such as the recruitment rate, retention rate, adherence, fidelity and engagement [50]. Acceptability reflects the extent to which providers or patients who participate in intervention consider it appropriate based on expected or experienced emotional and cognitive reactions to the intervention [51].

For data extraction regarding feasibility indicators, we included indicators as defined by previous studies [50, 52]. The extracted data included: the eligibility rate, recruitment rate, retention rate, drop-out rate, attendance of intervention’ sessions, fidelity, resources, statements regarding adaptation for the population and others. Concerning the acceptability indicators, we included data as defined by the authors if they explained how they measured acceptability (i.e., we employed patient’ satisfaction with the psychoeducational intervention as a measure, as assessed through qualitative or quantitative methods). The extracted acceptability indicators included: stakeholder acceptance, emotional and psychological effects of intervention, ethical considerations, patient satisfaction with the interventions, areas of concern, and contextual factors affecting acceptability. Last, we considered the outcome measurements reported by the authors. The extracted data included outcomes related to ADHD symptoms, skills, knowledge, quality of life, patient satisfaction, self-efficacy or self-esteem, functioning and impairment, and other reported outcomes.

Authors (TS, CdlC, and ÅH) independently extracted the feasibility criteria, acceptability, quality of reporting research (using the checklist items of Consolidated Standards of Reporting Trials, [CONSORT]) and outcomes used in psychoeducational group interventions. Disputes between the authors were resolved through discussion. Following the data charting, a narrative synthesis of the included studies was performed by summarizing the findings related to feasibility and acceptability indicators, as well as outcome measures used. This process aimed to identify patterns, gaps, and trends in the existing literature. The synthesis of the data was carried out based on predefined data-charting forms, and the final version of the extracted data was presented in the result tables and Additional File 2.

Results

The searches yielded 7510 publications. The initial screening of titles and abstracts identified 22 potential studies for comprehensive full-text assessment. Of the 22 articles initially categorized as educational interventions for adults with ADHD, 14 were excluded. Due to the non-psychoeducational nature of the intervention after the full-text assessment, 10 studies were excluded. One of each of the following was excluded: a theoretical article, conference paper, study protocol, and psychoeducational chat-bot intervention. This exclusion left eight articles. Figure 1 illustrates the screening process and Additional File 4 provides information on the excluded publications.

Characteristics of the studies

All included studies were conducted in one of five countries: two from Sweden [44, 53], three from Germany [5456], one from Spain [43], one from Netherlands [57], and one from the USA [58]. The number of participants in these studies ranged from 27 to 179. Among the studies, seven included patients from outpatient settings [43, 44, 5357], with two also incorporating significant others into the study [44, 53]. One study focused on college students diagnosed with ADHD [58].

Six studies were conducted in outpatient clinics [43, 44, 5355, 57], while one took place in the student healthcare center [58], and one study was performed at a university clinic [56]. Six studies utilized a RCT design [43, 5357], one employed a pre-post evaluation design [58], while the last was an open feasibility trial [44]. Of the six RCTs, two studies compared the effects of psychoeducational group interventions with Mindful Awareness Practices [54, 55], one study compared the effects of psychoeducation with the effect of cognitive-behavioral therapy [43], one study compared the effects of psychoeducation alone with those of a combination of psychoeducation and goal management training [57], one study compared psychoeducation with a waiting-list control group [53], and one study compared the same psychoeducational program in two groups delivered by two different methods, digital or pen-and-paper [56]. Only one RCT study [53] stated that the research followed the CONSORT reporting guidelines, and none reported using the Transparent Reporting of Interventions in Educational Research guidelines.

The duration of the group psychoeducational programs varied among the studies. Two studies reported a psychoeducational program consisting of 12 weekly sessions [43, 57], while five studies described eight weekly psychoeducational sessions [44, 5356]. Additionally, one study reported six weekly group-based sessions [58]. It is noteworthy that two studies, both conducted by Hirvikoski et al., were based on the same psychoeducational program, PEGASUS [44, 53]. Table 1 presents more detailed information concerning the studies and interventions.

Table 1.

Study characteristics

Study ID, author, year Country, setting Study design Number of participants Reporting guidelines Sample size calculation Intervention, description Psychoeducation, number of sessions
Vidal, 2013 [43] Spain, outpatient clinic Randomized, prospective, controlled two-arm study n = 32 participants: 15 in the psychoeducation group (PE) and 11 in the cognitive behavioral therapy group (CBT) Not reported Not reported

Group-based interventions. Both interventions (PE and CBT) were conducted by the same two clinical psychologists

Psychoeducation focused on ADHD education and information, without practice skills or homework tasks. The CBT program focused on coping skills training and included limited psychoeducation

12 weekly sessions, over 3 months, 2 h each
Hirvikoski, 2015 [44] Sweden, two outpatient tertiary psychiatric clinic Open clinical feasibility trial

n = 108 participants:

51 with ADHD and 57 significant others (SO)

Not reported

Not

reported

The PEGASUS program was described: a group psychoeducational program incorporating CBT, neuropsychology, and ADHD evidence

Delivered by a group leader: psychiatrist, psychologist or occupational therapist, an individual with ADHD, social worker, an employee from a local employment service and from local municipality services

The program focused on increasing knowledge about ADHD, treatment, support options in psychiatric care, and improving quality of life and relationship with significant others

eight weekly sessions

2.5 h each, 30 min break

Hirvikoski, 2017 [53] Sweden, two outpatient tertiary psychiatric clinic Pragmatic parallel group design, multicenter randomized controlled trial

n = 179 participants:

87 with ADHD, 92 SO

Intervention group (IG): 48 ADHD, 49 SO,

Control group (CG): 39 ADHD, 43 SO

CONSORT for reporting parallel groups randomized control trials

Was conducted:

0.80 power (at alpha level of .05) required approximately 50 participants with ADHD in each group

IG received manualized PEGASUS program in addition to treatment as usual

CG received standard clinical services (not further specified)

The PEGASUS groups included 10–15 adults with ADHD + at least as many SO

Other information: the intervention is the same as in Hirvikoski et al.’s, 2015 study

8 weekly sessions

2.5 h each, 30 min break

In de Braek, 2017 [57] Netherlands, outpatient setting Randomized controlled trial

n = 27

IG: Goal Management Training (GMT) in combination with PE, n = 12

CG: PE, n = 15

Not reported

Not

reported

IG received GMT in combination with PE. The intervention aimed to improve participants’ planning and strategy skills (GMT) and PE

CG received the same psychoeducational sessions as IG, but did not receive GMT

12 weekly sessions 1.5 h each, 1 individual session and 11 group sessions
Hoxhaj, 2018 [54] Germany, outpatient setting

Randomized controlled trial with a

factorial design

n = 81 medication-free adult ADHD patients

PE, n = 40

MAP, n = 41

Not reported

Was conducted:

To detect effect size of d = 0.6, a sample of 72

participants were required. 82 randomized

patients were planned

One group received a group-based PE program, the other group received MAP

The groups were conducted by trained psychotherapists and experts in CBT and mindfulness-based cognitive therapy (MBCT)

MAP group sessions and homework: daily meditation and mindfulness exercises

PE: provided information about ADHD in adulthood and the activation of organizational skills, stress management techniques, and self-esteem

8 weekly sessions of 2.5 h
Bachmann, 2018 [55] Germany, outpatient setting Randomized control fMRI study n = 74, 37 in each group, PE and MAP Not reported

Not

reported

One group received group-based PE program; the other group received MAP

Other information: the intervention was the same as in Hoxhaj et al.’s, 2018 study

8 weekly sessions of 2.5 h each,

Hartung,

2022 [58]

USA, university campus, two psychology training clinics Pre-post design

n = 30

students from two universities

Not reported

Was conducted:

27 participants were necessary to achieve adequate power (0.80) to detect a medium

effect size (d = 0.50) using matched pairs t-tests

Group and individual sessions of PE. PE included information about ADHD, treatment options, and coping (comprising planning and academic skills)

Delivered by advanced graduate student therapists and licensed clinical psychologists

The intervention was designed specifically for college students with ADHD. The intervention was focused on organizational, time management, and planning skills and demands of college students

6 group sessions, 3 individual sessions

All sessions were held across 6 weeks. Only 2 sessions were defined as psychoeducation

Selaskowski, 2022 [56] Germany, university clinic Randomized controlled trials

n = 60 participants,

30 in smartphone-assisted PE (SAP),

30 in brochure-assisted PE (BAP)

Not reported

Not

reported

One group received SAP, the other group received BAP

The groups were led by experienced therapists

The content of the group intervention was identical in both groups, only the work materials and format were different: SAP in digital form, BAP in pen-and-paper form

The program consisted of psychoeducation content, homework assignments, and a content quiz

8 weekly group-based psychoeducational sessions

ADHD Adult Attention Deficit/Hyperactivity Disorder, BAP Brochure-assisted psychoeducation, CBT Cognitive behavioral therapy, CG Control group, CONSORT Consolidated Standards of Reporting Trials, GMT Goal Management Training, IG Intervention group, MAP Mindful Awareness Practices, MBCT Mindfulness-Based Cognitive Therapy, PE Psychoeducation, SAP smartphone-assisted psychoeducation, SO Significant others, N Total number of participants

Regarding demographic data, most of the studies [43, 44, 53, 54, 56, 57] reported information on patients’ age, gender, level of education, some studies in addition reported ADHD subtype and employment status [43, 44, 53, 54, 56]. Some studies provided details on the number of years since ADHD diagnosis [44, 53] and the presence of co-morbid psychiatric disorders [5356] (Table 4).

Table 4.

Outcomes measures used to evaluate the interventions

Study ID, author, year Variables reported at baseline Outcomes reported at baseline Reported at post-intervention or follow-up ADHD symptoms Skills Measures of knowledge Self-rated scales not validated in ADHD Quality of life or well-being Patient satisfaction Self-efficacy or self-esteem  Functioning and impairment Other outcomes reported
Vidal, 2013 [43] Age, gender, marital status, level of education, work status, ADHD subtype, medication

Primary:

ADHD-RSa;

CAARS-Sa;

CGI-S

Secondary:

BDI;

STAI;

QLESQa

Same as baseline at post intervention

ADHD-RSa;

CAARS-Sa;

CGI-S

No No

BDI;

STAI;

CGI-S

QLESQa No No No No
Hirvikoski, 2015 [44]

For patients: age, gender, ADHD subtype, years diagnosed with ADHD, treatment, work status, education, Full-scale IQ,

WURS-25*, ASRS*

ADHD 20 Questions (knowledge quiz, 20 true/false items)

QAFM;

BDI;

BAI;

PSS;

RSE;

AAQoLa

Same as baseline at post intervention and 6 months follow-up

WURSa;

ASRSa

No ADHD 20 Questions (knowledge quiz, 20 true/false items)

QAFM

BDI;

BAI;

PSS;

RSE

AAQoLa

Treatment satisfaction; Rating course from 0 to 4; Session evaluation form at the end of each course session (completed anonymously)

RSE

RSE No QAFM
Hirvikoski, 2017 [53]

Patients: age, gender, ADHD subtype, years since diagnosed, early psychiatric care, current treatment, work status, education

SO: age, gender, work status, education, relation to the patients

Primary:

ADHD 20 Questions, (knowledge quiz, 20 true/false items)

Secondary:

SWLS;

HADS;

QAFM;

RSE;

SO: BAS

Same as baseline at post-intervention and follow-up

WURSa;

ASRSa

No ADHD 20 Questions, (knowledge quiz, 20 true/false items)

HADS;

SWLS; RSE

QAFM

SWLS Session evaluation form at the end of each course session (completed anonymously); Modified evaluation scale focusing on gained knowledge RSE No

QAFM;

BAS;

Adverse effects

In de Braek, 2017 [57] Age, gender, education (years), use of the medication

CIBIS/C;

SCL-90;

CFQ;

Zoo Map (BADS)

Same as baseline

CIBIS

CIBIC

SCL-90

Zoo Map (BADS) No

CIBIS/C;

SCL-90;

CFQ

No No No CFQ No

Hoxhaj,

2018 [54]

Age, gender, ADHD subtype, marital status, education, IQ, employment status, co-morbidities

WURS-k*

Primary outcomes:

CAARSa inattention/memory subscale

Secondary outcomes:

CAARSa

subscales (observer-rated and self-rated);

BDI;

BSI;

SF-36;

FFMQ

Same as baseline CAARSa FFMQ No

BSI;

BDI;

BSI;

SF-36;

FFMQ

SF-36 No No No FFMQ
Bachmann, 2018 [55] Age, education, gender, ADHD subtype, medication, comorbid psychiatric disorder, current and lifetime

CAARSa self- and blind observer

measurement of brain activation in the frontoparietal regions and basal ganglia; working memory task during fMRI;

Same as baseline CAARSa Working memory task during fMRI No No No No No No fMRI

Hartung,

2022 [58]

Age, gender, race, level of education, previous diagnosis of ADHD

DSM-5;

WFIRS;

CAARSa;

OTMP

Same as baseline DSM-5; CAARSa OTMP No

OTMP;

WFIRS

No Qualitative No

WFIRS;

OTMP

No
Selaskowski., 2022 [56] Age, gender, education level, employment status, ADHD subtype, pharmacological treatment, comorbid disorders

IDA-Ra;

BDI-II;

WFIRS;

MWT-B;

WURS-ka;

Content quiz

IDA-Ra;

BDI-II;

WFIRS;

Content quiz

DSM-5;

IDA-Ra

No Content quiz at the end of each module

MWT-B;

BDI-II;

WFIRS

No No No WFIRS MWT-B

aAuthors reported the scale was validated among ADHD

AAQoL Adult Attention Deficit/Hyperactivity Disorder Quality-of-Life, ADHD-RSADHD–Rating Scale, ASRS Adult ADHD Self-Report Scale, BAI Beck Anxiety Inventory, BAS Burden Assessment Scale, BDI Beck Depression Inventory, BSI Brief Symptom Inventory, CAARS Conners Adult ADHD Rating Scale, Long Version, CAARS-S Conners Adult ADHD Rating Scale, Shor Version, CFQ Cognitive Failures Questionnaire, CGI-S Clinical Global Impression–Severity Scale, CIBIS/C Clinician’s Interview-Based Impression of Severity/Change, FFMQ Five-Facet Mindfulness Questionnaire, HADS Hospital Anxiety and Depression Scale, IDA-R Integrated Diagnosis of ADHD in Adulthood, MWT-B Mehrfachwahi-Wortschat Test, OTMP Organizational Time Management and Planning, self-reported, PSS Perceived Stress Scale, QAFM Questions about family members, QLESQ Quality of Life Enjoyment and Satisfaction Questionnaire, RSE Rosenberg’s Self-Esteem, SF-36 36-Item Short Form Health Survey, SCL-90 Symptom Check List-90, STAI State-Trait Anxiety Inventory, SWLS Satisfaction With Life Scale, WFIRS Weiss Functional Impairment Rating Scale, WURS-25 Wender Utah Rating Scale, Zoo Map (BADS) Zoo Map for the Behavioral Assessment of the Dysexecutive Syndrome

Feasibility indicators

Regarding the PEGASUS intervention, the authors pre-defined acceptable levels of feasibility indicators, such as a dropout rate of no more than 25% and treatment completion of at least 50% of attended sessions [44, 53]. Only two studies reported the eligibility rate [54, 56], which was 52% and 28%, respectively. More information is presented in Table 2.

Table 2.

Feasibility indicators

Characteristics Vidal, 2013 [43] Hirvikoski, 2015 [44] Hirvikoski, 2017 [53] In de Braek, 2017 [57] Hoxhaj, 2018 [54] Bachmann, 2018 [55] Hartung,2022 [58] Selaskowski, 2022 [56]

Dates of recruitment

(YYYY.MM)

- - 2012.03 to 2013.12 - 2012 to 2013 - - 2019.03 to 2020.11
Eligibility rate1 - - - -

52%

(103 out of 200 were eligible)

- -

28%

(67 out of 236 were eligible)

Recruitment rate2

80%

(32 out of 40)

Patients: 96.2% (51 out of 53); SO: 89% (57 out of 64)

IG, patients: 95.8% (46 out of 48); SO: 93.9% (46 out of 49)

CG, patients: 94.9% (37 out of 39); SO: 95,3% (41 out of 43)

-

78.6%

(81 out of 103 invited participants were randomized)

- -

94%

(63 out of 67)

Session attendance - - Patients attended 86% of the sessions; SO attended 79% of the sessions - - -

Attendance at mandatory group sessions

was 87%

SAP: mean = 6.7 sessions

BAP: mean = 6.9 sessions

Retention rate at post intervention

93.75%

(30 out of 32)

Patients: 84.3% (43 out of 51)

SO: 73.7% (42 out of 57)

IG, patients: 93.8% (45 out of 48);

SO: 89.8% (44 out of 49)

CG, patients: 87.2% (34 out of 39); SO, 83.7% (36 out of 43)

IG: 83% (10 out of 12)

CG: -

PE: 90% (36 out of 40); MAP: 95% (39 out of 41) PE: 73% (27 out of 37); MAP: 86.5% (32 out of 37) 100%

SAP: 86.7% (26 out of 30)

BAP: 66.6% (20 out of 30)

Retention rate at follow-up

81.25%

(26 out of 32)

At 6-months follow-up

Patients: 80% (41 out of 51),

SO: 70% (40 out of 57)

At 3-months follow-up

IG, patients: 87.5% (42 out of 48); SO: 73.5% (36 out of 49)

CG, patients: 79.5% (31 out of 39); SO: 72.1% (31 out of 43)

At 12 weeks follow-up

IG: 66,7% (8 out of 12)

CG: -

At 24 weeks follow-up:

IG: 50% (6 out of 12)

CG: -

At 6-months follow up

PE: 80% (32 out of 40); MAP: 78% (32 out of 41)

- - -
Drop-out rate

6%

(2 out of 30)

Patients: 15.6% (8 out of 51)

SO:

29.3% (15 out of 57)

IG, patients: 4.2% (2 out of 48), SO: 8.3% (4 out of 48)

CG: patients: 5.1% (2 out of 39), SO: 4.7% (2 out of 43)

IG: 17% (2 out of 12)

CG: -

PE: 10% (4 out of 40); MAP: 4.9% (2 out of 41)

PE: 27%, 10 out of 37

MAP: 13.5%, 5 out of 37

0

Total: 27% (17 out of 63 randomized)

SAP: 13.3% (4 out of 30)

BAP: 33.3% (10 out of 30)

Evidence of reliability and validity of PROM and PREM in the target population3

Partially

reported

Only one scale

Partially

reported

Partially

reported

Partially

reported

Partially

reported

Partially

reported

Partially

reported

Resources used Two clinical psychologists were trained to adhere to the content of each treatment Two group leaders were provided with workbooks, lecture materials, and other informational materials Workbooks for course leaders and handbooks for participants. Lecture material such as PowerPoint presentations were provided for group leaders Two clinical neuropsychologists conducted the intervention, one blinded neuropsychologist conducted the clinical assessment Two therapists conducted the intervention Intervention was given by health professionals Graduate students under the supervision of clinical psychologists Intervention was given by two therapists; paper materials were used in the BAP group
Risk assessment - - - - - - - -
Key stakeholders included - - - - - - - -
Statements regarding adaptation for the population - The intervention was developed especially for adults with ADHD The intervention was developed especially for adults with ADHD - - - The intervention was developed especially for college students with ADHD -
Implementation - - - - - - - -
Potential barriers - - - - - - - -
Fidelity

Partially

reported

Partially

reported

No significant deviations from the intended PE program were noted

Partially

reported

To ensure fidelity to

the manual and quality assurance of both group programs,

all therapy sessions were video recorded

Partially

reported

Partially

reported

Partially

reported

Other issues reported - - In an outpatient psychiatric context, scarce resources (such as sufficient time) may hamper the implementation of new methods -

Authors reported the PE was easier to implement, while the MAP groups necessitated specially

trained therapists

Insufficient behavioral responses during conducting fMRI or - Participant needed access to a smartphone with Android OS

Not reported, ADHD attention deficit/hyperactivity disorder, CG control group, fMRI functional magnetic resonance imaging, IG Intervention group, MAP Mindfulness training, PE Psychoeducation, PREM Patient reported experiences, SO significant other

aEligibility rate defined as the number of participants eligible divided by n of participants screened (n or %)

bRecruitment rate defined as n of participants accepting the invitation, divided by n of participants invited

cAuthors reported evidence of reliability and validity of measures in the target population; or there is evidence of psychiatric properties in the target population

The recruitment rate was reported in five studies, ranging from 78.6% [54] to 96.2% [44]. All studies reported a retention rate, with the lowest rate being 66.6% [56], and the highest being 100% [58]. Session attendance was reported in three studies [53, 56, 58], with two at 86% and 87% [53, 56], and the last study reported a mean attendance of 6.7 to 6.9 out of eight group sessions [58].

All studies reported dropout rates from the interventions, with the highest dropout rate 27% [55, 56] and the lowest 0% [58]. Only one study reported an assessment of the feasibility of the interventions regarding the implementation cost [58]. Additional information is presented in Table 2.

Acceptability indicators and patient satisfaction

Acceptability was operationalized in different ways across the studies (qualitative and quantitative). The Evaluation Questionnaire was used to measure satisfaction with the intervention in two studies [44, 53] and reached at least mean score equal 2.5 (the scale range is from 0 to 4) in one study [44], and mean score equal 3 (in 7 out of 8 occasions) in the other study [53]. In one of these studies [44], patient satisfaction was reported using patients’ rates on the course and session evaluation form and reached mean value equal 2.21 (SD = 0.72, the range of the score is from 0 to 3). Table 3 presents more detailed information about the acceptability characteristics of the studies.

Table 3.

Acceptability indicators

Study ID, author, year Tools and methods for measuring acceptability Stakeholder acceptance Emotional and psychological effect of the intervention Ethical considerations Acceptability and/or patient satisfaction with the group intervention Areas of concern Contextual factors affecting acceptability
Vidal, 2013 [43] Not reported Not reported Not reported Yes, this study was approved by the ethics committee of the hospital, and all the participants signed an informed consent document Not reported Not reported Not reported
Hirvikoski, 2015 [44] Modified version of the evaluation form, rating the course, session evaluation form (SEF) to get feedback Not reported Not reported Yes, the study was approved by the Regional Ethics Committee of Stockholm (2009/824–31/3) Treatment satisfaction was good, patients with ADHD showed more willingness to participate in the future than SO Not reported Not reported
Hirvikoski, 2017 [53] Modified version of the evaluation questionnaire Not reported No adverse events (any inconvenience that a participant reported) or serious adverse events (anything that required inpatient hospitalization) were judged to be related to the program per se Yes, the study was approved by the Regional Ethics Committee of Stockholm in 2012 (2012/422–31/3), and all participants gave their informed consent The participants reported generally good treatment satisfaction Not reported For resource saving reasons, psychoeducational groups were relatively large: 10–15 adults with ADHD and at least as many SO
In de Braek, 2017 [57] Not reported Not reported Not reported Not reported Not reported Not reported 6–8 participants in each group, to ensure that the training functioned optimally
Hoxhaj, 2018 [54] Not reported Not reported Not reported Yes, the study was approved by the local ethics committee of the University of Freiburg Not reported Not reported Not reported
Bachmann, 2018 [55] Not reported Not reported Not reported

Yes, the study was approved by the local ethics committee and registered in the Current Controlled

Trials database (ISRCTN12722296)

Not reported Not reported Not reported
Hartung, 2022 [58] Qualitative feedback from the participants Not reported Not reported Not reported

Participants reported satisfaction with the intervention,

both during and after completion, suggesting that it is easily tolerated

30% of students prescribed ADHD medication misuse it at some point in their college careers, stigmatization is a concern Not reported
Selaskowski, 2022 [56] Not reported Not reported No adverse events or unintended consequences were reported The study was approved by the ethics committee of the University of Bonn (232/18), and written consent was obtained Not reported Not reported The intervention was addressed only to the participants familiar with smartphones

ADHD attention deficit/hyperactivity disorder, SO significant other

Outcomes measures used to evaluate the interventions

Regarding ADHD symptoms, four studies [43, 54, 55, 58] used Conners’ Adult ADHD Rating Scale (CAARS [59]), and two studies [44, 53] used Adult ADHD Self-Report Scale (ASRS [60]), while four studies [44, 53, 54, 56] used the Wender Utah Rating Scale (WURS [61]) to assess the diagnosis of ADHD at baseline. One study [56] used the Integrated Diagnosis of ADHD in Adulthood (IDA-R [62]) and one study [57] used the Clinician’s Interview-Based Impression of Severity (CIBIS [63]) and Symptom Check List–90 (SCL-90 [64]). Five studies reported depression and anxiety symptoms [43, 44, 53, 54, 56] using different scales. Additionally, the Perceived Stress Scale (PSS [65]) was used to measure stress Hirvikoski et al.’s, (2015) study [44]. Quality of life or global life satisfaction was reported, using different measurement scales. For detailed information, see Table 4.

Reported main findings

All studies exhibit significant improvements in one or more outcome measures. Six of eight studies reported improvement in ADHD symptoms over time [43, 5458], but only two RCTs displayed improvement in symptom domains between groups [56, 57]. Two studies reported improvement in anxiety and depression symptoms [43, 44], one reported improvement in the subjective stress level over time [44], and one reported improvement in ADHD-related impairment [53, 58]. Two studies indicated improvement in the level of knowledge regarding ADHD [44, 53], and one indicated improvement in self-esteem after intervention [43]. Three studies reported improvement in other outcomes. Bachmann et al. (2018) [55] found improvement in task performance; Hartung et al. (2022) [58] reported improvement in organization, time management and planning skills; finally, Selaskowski et al. (2022) [56] reported improvement homework compliance after the intervention. Only one study reported significant improvement in the quality of life over time [43].

Discussion

The primary goal of this scoping review was to map the existing evidence reported on psychoeducational group interventions for adults diagnosed with ADHD. The objective was to provide a comprehensive overview of feasibility indicators, acceptability, and outcome measures used in these interventions. We identified eight studies that satisfied the inclusion criteria.

Although all included studies reported some feasibility indicators, and only one study was characterized as a feasibility study [44], the results were heterogeneous and problematic to compare. For instance, recruitment was primarily presented through a flow chart, making it challenging to assess the various feasibility criteria. Few studies made any predefined assumptions about feasibility [44, 53].

Hirvikoski et al. [44] applied their inclusion criteria to sample selection from the general ADHD clinical population. This type of approach is useful because the high frequency of psychiatric and somatic comorbidities in adult ADHD patients [66] could result in strict inclusion criteria that exclude a large portion of this population and thereby limit the potential for large-scale implementation of the intervention. Although the reported interventions had broad inclusion criteria, some studies used concurrent psychopathology and medication use as exclusion criteria [43, 54, 57]. Data on the recruitment period and eligibility rate were mostly lacking, making it challenging to identify crucial feasibility characteristics, such as the duration of the study or the degree of suitability of the intervention for ADHD patients.

Three studies reported high attendance rates [53, 56, 58]. Factors like scheduling conflicts could be potential barriers to programming the implementation [67]. Only the study by Hartung et al. [58] reported this barrier and tailored its intervention to the participants’ needs. Moreover, their study was the only one to consider the cost of the study for the participants. Their study reported the lowest drop-out rate and highest attendance rate, even though indirect and direct costs can represent barriers to enrollment and participation in psychoeducational programs [67]. Attendance at the sessions may reflect patients’ adherence to the treatment and thus provide information about how critical the intervention is for the participants [51]. The reporting on this outcome, however, was generally sparse and variable. Only two studies [44, 53] reported predefined criteria for attendance rates. Considering that these interventions are in the initial stages of development, future studies on the development and evaluation of psychoeducational group programs should prioritize reporting attendance measures. The scarcity of data on the recruitment period and eligibility rate, coupled with the lack of standardization of feasibility indicators, necessitates further research.

Only the study by Hirvokiski et al. [53] stated that the research followed the CONSORT reporting guidelines for an RCT study (Additional File 2). The other studies did not indicate the use of guidelines or recommendations for RCT or feasibility research in their studies. Compliance with guidelines increases the transparency of research and promoting deeper and more critical analysis by other researchers [68]. Additionally, only three studies reported sample size calculations [53, 54, 58], although this is a vital element when conducting clinical trials to demonstrate significant differences [69]. Thus, future studies should follow and indicate compliance with reporting guidelines to provide a template for the intervention description and replication framework [70]. In addition, future studies should prioritize conducting more rigorous research regarding determining appropriate sample sizes and reporting recruitment feasibility challenges to facilitate a better understanding of the feasibility and effects of such interventions.

Assessing acceptability and patient satisfaction is vital in developing new interventions in clinical settings [51]. This review reveals that acceptability, defined as patient satisfaction with the group intervention or the emotional and psychological effect of the intervention, went unreported in most interventions. Only three studies used evaluation questionnaires or other measures to assess the acceptability of an intervention [44, 53, 58]. Two studies reported patient satisfaction as ad hoc measures [44, 53], and one employed a qualitative approach to assess satisfaction [58].

Another identified challenge is the use of modified and non-validated scales to report patient satisfaction. Standardization in reporting acceptability and patient satisfaction is crucial for developing and improving the content of interventions [51]. This aligns with the findings of previous studies that little attention has been paid to performance measures and the assessment of patient’ viewpoints [71]. Furthermore, using reliable outcome measures to report patient experiences can enhance practice, making the results meaningful in and of themselves and facilitating inter-study comparisons [72]. In addition, the use of validated scales and tools to measure participants’ experiences provides mental-healthcare decision-makers with the necessary information regarding meaningful outcomes for patients [73]. Therefore, the results of the current study strongly recommend using standardized and validated tools to measure the acceptability of and patient satisfaction with these psychoeducational group programs. Nevertheless, the findings should be interpreted with caution, given the methodological limitations and limited number of studies reporting on satisfaction.

The acceptability level of the interventions among mental-healthcare providers, stakeholders, and patient representatives involved in the interventions was not reported in the included studies. In addition, only the study by Hartung et al. reported the adaptivity criteria for participants’ needs [58]. This pattern may reflect little collaboration or a lack of involvement or support from users, mental-healthcare professionals, and clinicians, which requires further exploration. This finding also highlights that mental-healthcare services and funding should be involved in developing and evaluating such interventions [31]. Adapting psychoeducational group interventions can be essential for global mental health equity. Research in this area could lead to innovative, cost-effective solutions, ensuring that effective patient education for ADHD care is accessible to patients with economic constraints. Future studies should focus on developing sensitive and culturally acceptable interventions to meet patient needs (sociocultural or demographic).

According to guidelines for reporting the acceptability of healthcare interventions [51], studies should measure the emotional and psychological effect of the intervention. As only one study measured the potential emotional stress or adverse effects of the interventions [53], future studies should focus on assessing these adverse effects, as well as the emotional and psychological effects that the intervention might cause.

The findings of this scoping review underscore the positive influence of psychoeducational group interventions on adults with ADHD, particularly in improving ADHD symptoms. These results align with those of Nimmo-Smith et al. (2020) [20], Oliveira et al. (2018) [74], and Montoya et al. (2011) [30], who found that non-pharmacological interventions improve ADHD symptoms among children [30] and adults with ADHD [20, 74]. Moreover, the positive outcomes reported in this scoping review align with previous research highlighting the effectiveness of psychoeducational interventions in other psychiatric conditions. Studies on various conditions, such as schizophrenia [25], psychosis risk [26], bipolar disorder [27], depression [28], and anxiety [29], have similarly demonstrated improvement in patient knowledge, and symptom management following psychoeducational intervention. However, while all studies assessing patient-reported outcomes reported improvement in one or more outcomes, the findings also indicate the variability in outcome measures used.

All the included studies reported a variety of outcome measures, such as knowledge about ADHD, relationships with family members, psychological well-being, cognitive failures, ADHD core symptoms, and symptoms of anxiety and depression. Overall, four studies directly addressed quality of life [43, 44, 53, 54]. Only one study, by Hirvikoski et al. [44], used a specialized scale to measure the quality of life of adults with ADHD, while other studies used more general questionnaires for measuring quality of life, thus limiting the data-pooling potential for meta-analyses in future studies. Furthermore, as the studies used diverse outcome measures and operationalized quality of life and well-being differently, further understanding the effects of these psychoeducational group interventions on the quality of life is challenging. Consistently measuring and operationalizing this outcome in future research is necessary.

According to previous studies, knowledge [35], and self-efficacy [31] are important factors related to educational interventions. We did also find, however, that measuring these outcomes was rarely reported. None of the studies reported any effects on self-efficacy. Only three studies in this review measured knowledge gain, using a nonvalidated scale [44, 53, 56]. Although measuring knowledge gain is a critical outcome for improving treatment enrolment and adherence [75], barriers exist to measuring and interpretating knowledge gain [76]. To overcome these obstacles, we recommend using standardized validated PROMs to measure outcomes.

Previous studies have highlighted the value of group interventions by providing a forum through which participants can share their experiences with others, thereby increasing social support [31]. This aspect is particularly vital in addressing the social isolation and misunderstanding that many adults with ADHD face. The group setting provides a safe space for patients to connect with others who understand their struggles, fostering a supportive network that extends beyond the clinical environment. Still, studies measuring the social isolation and the stress levels in everyday life are lacking, highlighting the need for more research in this field.

The wide range of identified outcome measures investigating the effects of mental health outcomes found in this scoping review highlights the need to include similar scales in future studies. This approach would allow for the comparison and replication of findings and facilitate future systematic reviews and meta-analyses. When standard information on mental health outcomes becomes available, it will be possible to recognize and pinpoint the effects of the interventions, understand the mechanisms of improvement, and identify specific approaches that should be avoided, improved, or preferred in the context of ADHD.

Opportunities for improvement based on the available evidence on outcome measures used in the included studies were identified. Some studies used self-developed measures [44, 53, 56] or patient-reported outcomes without referring to their psychometric properties [44, 58]. Some studies also used patient-reported scales to measure anxiety and depression, but these scales have not been validated for the adult ADHD population [43, 44, 53, 54, 56]. The evaluation of psychoeducational interventions requires adaptation and validation of PROMs and self-rated scales, considering these methodological limitations. Hence, these findings highlight the need for more studies using psychometric methods that employ validated self-reported scales specifically targeting ADHD. These adaptations and validations can add further research value, yielding meaningful pooled results in future systematic reviews and paving the way to compare and determine the effectiveness of psychoeducational interventions in the emerging mental-health field regarding the treatment of adults with ADHD.

Strengths and limitations

This scoping review was based on seven databases. It provides, for the first time, an overview of the feasibility and acceptability of psychoeducational group interventions for adults diagnosed with ADHD while offering an overview of the applied outcome measures. This review can assist researchers and guide future work on intervention development and research in this field. Although the findings provide knowledge to support health policymakers and clinicians with a broad understanding of psychoeducational group interventions for adults diagnosed with ADHD, the findings are limited to a few studies, indicating that this research is still in its early developmental stages. Including special subject databases such as PsycINFO is generally recommended when the review topic directly touches the primary focus of a database. The exclusion of PsycINFO from the most recent update of the literature search for this study means that some recent studies, unique to this database, could have been overlooked. This therefore represents another potential limitation in this study.

The inclusion criteria restricted the selection of studies to only those in English, limiting the findings and potentially introducing selection bias. Another limitation arises from the exclusive focus on group-based psychoeducational programs. Furthermore, most studies were conducted in outpatient settings with adult patients with ADHD, limiting the generalizability of their results to other populations. Additionally, while this study primarily focused on the acceptability of patients who received group psychoeducational programs, it does not assess the acceptability from the perspective of providers and stakeholders, which represents another limitation.

In addition, most of the included studies were from Europe, limiting the representativeness of the findings. Thus, future research addressing a more diverse population is necessary. Adapting these psychoeducational group interventions to lower-resource settings can be essential for global mental health equity. Research in this area could lead to innovative, cost-effective solutions, ensuring that effective patient education and ADHD care are accessible to patients with economic constraints.

Finally, we identified several outcome measures, but the findings are limited by the lack of standardize measurement of outcomes for feasibility, acceptability, and patient-reported outcomes and experiences. Educational group interventions can significantly affect the improvement of patient knowledge regarding the disorder [35], adherence, social and occupational functioning, and clinical outcomes [75]. Future studies could benefit from measuring such outcomes. Moreover, there are other outcomes on which educational group interventions can have an impact on, promoting peer support, coping strategies, and self-management outcomes (e.g. level of patient activation and self-efficacy [31]), that should be evaluated in future studies.

Conclusion

This scoping review revealed that psychoeducational group interventions are generally acceptable for patients in terms of patient satisfaction with the group intervention. All included studies reported some feasibility indicators, with some reporting good attendance and relatively low dropout rates. Most studies reported positive effects on ADHD and mental health symptoms, suggesting that these interventions are beneficial for adults with ADHD. Several gaps exist, however, regarding the reporting on feasibility indicators, acceptability, and outcome measures used across studies. Some studies have only partially followed standard reporting guidelines. Patient-reported outcomes were consistently incorporated into the existing studies. Patient-reported experiences regarding stress or the level of self-efficacy were lacking. Some critical aspects of acceptability, such as acceptability of providers and stakeholders, were missing. In addition, some studies used patient-reported outcomes that were not validated in adults diagnosed with ADHD. Future research should aim to fill these gaps regarding the lack of standardized feasibility criteria and limited reporting on acceptability and patient satisfaction.

Supplementary Information

Additional file 1. (26.4KB, docx)
Additional file 2. (45.1KB, docx)
Additional file 3. (49.2KB, docx)
Additional file 4. (40.7KB, docx)
Additional file 5. (135.7KB, docx)

Acknowledgements

Special thanks to Hege Hafstad, from the User-Led Center Vårres, Trondheim, Norway whose ideas, feedback and advice inspired this study.

Abbreviations

AAQoL

Adult attention deficit/hyperactivity disorder quality-of-life scale

ADHD

Attention deficit hyperactivity disorder

ASRS

Adult ADHD Self-report scale

BAI

Beck anxiety inventory

BDI

Beck depression inventory

BSI

Brief symptom inventory

CAARS

Conners’ adult ADHD rating scale

CFQ

Cognitive failures questionnaire

CGI-S

Clinical global impressions scale -severity

CIBIS/C

Clinician’s interview-based impression of severity/ change

CONSORT

Consolidated standards of reporting trials

FFMQ

Five facet mindfulness questionnaire

fMRI

Functional magnetic resonance imaging

GMT

Goal management training

HADS

Hospital anxiety and depression scale

IDA-R

Integrated diagnosis of adhd in adulthood

MWT-B

Mehrfachwahi-wortschat-test

PE

Psychoeducation

PREM

Patient reported experiences

PRISMA-ScR

The preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews

PROM

Patient-reported outcome measure

PSS

Perceived stress scale

QAFM

Questions about family members

QLESQ

Quality of life enjoyment and satisfaction

RCT

Randomized controlled trial

RSE

Rosenberg’s self-esteem scale

SCL-90

Symptom check list-90

SF-36

36-Item short form health survey

STAI

State trait anxiety inventory

SWLS

Satisfaction with life scale

WFIRS

Weiss functional impairment rating scale

WURS

Wender utah rating scale

Zoo Map (BADS)

Zoo map for the behavioral assessment of the dysexecutive syndrome

Authors’ contributions

TS: Conceptualization, methodology, screening, data analysis/interpretation, writing – original draft, and writing – review & editing. HP: Screening, data extraction, writing – review & editing. SAP: Data curation, development of search strategy, searching for literature, writing – review & editing. ÅH: Screening, data extraction, writing – review & editing. AM: Conceptualization, writing – review & editing. CdlC: Screening, writing – review & editing, extracting data. AH: Screening, writing – review & editing, supervision. RG: Conceptualization, screening, writing – review & editing, supervision. MLL-C: Conceptualization, screening, methodology, writing – review & editing, supervision. All authors reviewed and confirmed the final version of the manuscript.

Funding

Open access funding provided by Norwegian University of Science and Technology This project was founded by Central Norway Regional Health Authority (Samarbeidsorganet, project no.983433100 and 90839300).

Availability of data and materials

All data generated or analysed during this review are included in this published article and its supplementary information files.

Declarations

Ethics approval and consent to participate

This was a synthesis of already published data and did not require ethical approval.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests. 

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Zalsman G, Shilton T. Adult ADHD: A new disease? Int J Psychiatry Clin Pract. 2016;20(2):70–76. doi: 10.3109/13651501.2016.1149197. [DOI] [PubMed] [Google Scholar]
  • 2.American Psychiatric Association, D. S. M. T. F., American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Vol. 5. No. 5. Washington, DC: American psychiatric association; 2013.
  • 3.Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021;11:04009. doi: 10.7189/jogh.11.04009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240–1250. doi: 10.1016/S0140-6736(15)00238-X. [DOI] [PubMed] [Google Scholar]
  • 5.Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. Functional impairment and occupational outcome in adults with ADHD. J Atten Disord. 2012;16(7):544–552. doi: 10.1177/1087054711413074. [DOI] [PubMed] [Google Scholar]
  • 6.Halmoy A, Fasmer OB, Gillberg C, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13(2):175–187. doi: 10.1177/1087054708329777. [DOI] [PubMed] [Google Scholar]
  • 7.Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627. doi: 10.1001/archpsyc.62.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Rasmussen K, Levander S. Untreated ADHD in adults: are there sex differences in symptoms, comorbidity, and impairment? J Atten Disord. 2009;12(4):353–360. doi: 10.1177/1087054708314621. [DOI] [PubMed] [Google Scholar]
  • 9.Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry. 2006;60(1):38–43. doi: 10.1080/08039480500520665. [DOI] [PubMed] [Google Scholar]
  • 10.Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 2010;25(3):157–173. doi: 10.1093/arclin/acq014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723. doi: 10.1176/ajp.2006.163.4.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Adler LA, Spencer TJ, Levine LR, Ramsey JL, Tamura R, Kelsey D, Ball SG, Allen AJ, Biederman J. Functional outcomes in the treatment of adults with ADHD. J Atten Disord. 2008;11(6):720–727. doi: 10.1177/1087054707308490. [DOI] [PubMed] [Google Scholar]
  • 13.Safren SA, Sprich SE, Cooper-Vince C, Knouse LE, Lerner JA. Life impairments in adults with medication-treated ADHD. J Atten Disord. 2010;13(5):524–531. doi: 10.1177/1087054709332460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Aydin Ü, Capp SJ, Tye C, Colvert E, Lau-Zhu A, Rijsdijk F, Palmer J, McLoughlin G. Quality of life, functional impairment and continuous performance task event-related potentials (ERPs) in young adults with ADHD and autism: A twin study. JCPP Adv. 2022;2(3):e12090. doi: 10.1002/jcv2.12090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lebowitz MS. Stigmatization of ADHD: A Developmental Review. J Atten Disord. 2016;20(3):199–205. doi: 10.1177/1087054712475211. [DOI] [PubMed] [Google Scholar]
  • 16.Newark PE, Elsässer M, Stieglitz R-D. Self-Esteem, Self-Efficacy, and Resources in Adults With ADHD. J Atten Disord. 2016;20(3):279–290. doi: 10.1177/1087054712459561. [DOI] [PubMed] [Google Scholar]
  • 17.Newark PE, Stieglitz R-D. Therapy-relevant factors in adult ADHD from a cognitive behavioural perspective. ADHD Attention Deficit and Hyperactivity Disorders. 2010;2(2):59–72. doi: 10.1007/s12402-010-0023-1. [DOI] [PubMed] [Google Scholar]
  • 18.Canadian, A. D. H. D. "Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines." Toronto: CADDRA; 2018.
  • 19.May T, Birch E, Chaves K, Cranswick N, Culnane E, Delaney J, Derrick M, Eapen V, Edlington C, Efron D, Ewais T. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023;57(8):1101–16. [DOI] [PMC free article] [PubMed]
  • 20.Nimmo-Smith V, Merwood A, Hank D, Brandling J, Greenwood R, Skinner L, Law S, Patel V, Rai D. Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020;50(4):529–541. doi: 10.1017/S0033291720000069. [DOI] [PubMed] [Google Scholar]
  • 21.National Guideline C. National Institute for Health and Care Excellence. 2018;03:03. [Google Scholar]
  • 22.Fullen T, Jones SL, Emerson LM, Adamou M. Psychological treatments in adult ADHD: a systematic review. J Psychopathol Behav Assess. 2020;42(3):500–18.
  • 23.Wakelin C, Willemse M, Munnik E. A review of recent treatments for adults living with attention-deficit/hyperactivity disorder. S Afr J Psychiatr. 2023;29:2152. doi: 10.4102/sajpsychiatry.v29i0.2152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Simonsmeier BA, Flaig M, Simacek T, Schneider M. What sixty years of research says about the effectiveness of patient education on health: a second order meta-analysis. Health Psychol Rev. 2022;16(3):450–474. doi: 10.1080/17437199.2021.1967184. [DOI] [PubMed] [Google Scholar]
  • 25.Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011;2011(6):Cd002831. doi: 10.1002/14651858.CD002831.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Herrera SN, Sarac C, Phili A, Gorman J, Martin L, Lyallpuri R, Dobbs MF, DeLuca JS, Mueser KT, Wyka KE, et al. Psychoeducation for individuals at clinical high risk for psychosis: A scoping review. Schizophr Res. 2023;252:148–158. doi: 10.1016/j.schres.2023.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Batista TA, Von Werne BC, Juruena MF. Efficacy of psychoeducation in bipolar patients: Systematic review of randomized trials. Psychology & Neuroscience. 2011;4:409–416. doi: 10.3922/j.psns.2011.3.014. [DOI] [Google Scholar]
  • 28.Tursi MF, Baes C, Camacho FR, Tofoli SM, Juruena MF. Effectiveness of psychoeducation for depression: a systematic review. Aust N Z J Psychiatry. 2013;47(11):1019–1031. doi: 10.1177/0004867413491154. [DOI] [PubMed] [Google Scholar]
  • 29.Dolan N, Simmonds-Buckley M, Kellett S, Siddell E, Delgadillo J. Effectiveness of stress control large group psychoeducation for anxiety and depression: Systematic review and meta-analysis. Br J Clin Psychol. 2021;60(3):375–399. doi: 10.1111/bjc.12288. [DOI] [PubMed] [Google Scholar]
  • 30.Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. European Psychiatry: the Journal of the Association of European Psychiatrists. 2011;26(3):166–175. doi: 10.1016/j.eurpsy.2010.10.005. [DOI] [PubMed] [Google Scholar]
  • 31.Stenberg U, Haaland-Øverby M, Fredriksen K, Westermann KF, Kvisvik T. A scoping review of the literature on benefits and challenges of participating in patient education programs aimed at promoting self-management for people living with chronic illness. Patient Educ Couns. 2016;99(11):1759–1771. doi: 10.1016/j.pec.2016.07.027. [DOI] [PubMed] [Google Scholar]
  • 32.Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10(1):67. doi: 10.1186/1471-244X-10-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bisset M, Brown LE, Bhide S, Patel P, Zendarski N, Coghill D, Payne L, Bellgrove MA, Middeldorp CM, Sciberras E. Practitioner Review: It's time to bridge the gap - understanding the unmet needs of consumers with attention-deficit/hyperactivity disorder - a systematic review and recommendations. J Child Psychol Psychiatry. 2023;64(6):848–858. doi: 10.1111/jcpp.13752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Seery C, Wrigley M, O'Riordan F, Kilbride K, Bramham J. What adults with ADHD want to know: A Delphi consensus study on the psychoeducational needs of experts by experience. Health Expect. 2022;25(5):2593–2602. doi: 10.1111/hex.13592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Solberg BS, Haavik J, Halmoy A. Health Care Services for Adults With ADHD: Patient Satisfaction and the Role of Psycho-Education. J Atten Disord. 2019;23(1):99–108. doi: 10.1177/1087054715587941. [DOI] [PubMed] [Google Scholar]
  • 36.Ekhtiari H, Rezapour T, Aupperle RL, Paulus MP: Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective, vol. 235. New York; 2017. [DOI] [PMC free article] [PubMed]
  • 37.Scholz L, Werle J, Philipsen A, Schulze M, Collonges J, Gensichen J. Effects and feasibility of psychological interventions to reduce inattention symptoms in adults with ADHD: a systematic review. J Ment Health. 2023;32(1):307–20. [DOI] [PubMed]
  • 38.Koksvik JM, Linaker OM, Gråwe RW, Bjørngaard JH, Lara-Cabrera ML. The effects of a pretreatment educational group programme on mental health treatment outcomes: a randomized controlled trial. BMC Health Serv Res. 2018;18(1):665. doi: 10.1186/s12913-018-3466-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Long CG, Banyard E, Dolley O. Living with Mental Illness: A Cognitive Behavioural Group Psycho-education Programme with Women in Secure Settings. Clin Psychol Psychother. 2016;23(4):368–376. doi: 10.1002/cpp.1967. [DOI] [PubMed] [Google Scholar]
  • 40.Candini V, Buizza C, Ferrari C, Caldera MT, Ermentini R, Ghilardi A, Nobili G, Pioli R, Sabaudo M, Sacchetti E, et al. Is structured group psychoeducation for bipolar patients effective in ordinary mental health services? A controlled trial in Italy. J Affect Disord. 2013;151(1):149–155. doi: 10.1016/j.jad.2013.05.069. [DOI] [PubMed] [Google Scholar]
  • 41.Abadi MH, Barker AM, Rao SR, Orner M, Rychener D, Bokhour BG. Examining the Impact of a Peer-Led Group Program for Veteran Engagement and Well-Being. J Altern Complement Med. 2021;27(S1):S37–s44. doi: 10.1089/acm.2020.0124. [DOI] [PubMed] [Google Scholar]
  • 42.Hafstad E, Leiknes KA. Psychoeducation for Adults with Attention Deficit Hyperactivity Disorder (ADHD): Rapid Review [Internet]. Oslo: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2016. Report from the Norwegian Institute of Public Health No. 2016-26. PMID: 29553661. [PubMed]
  • 43.Vidal R, Bosch R, Nogueira M, Gomez-Barros N, Valero S, Palomar G, Corrales M, Richarte V, Mena B, Casas M, et al. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study. Journal of Nervous & Mental Disease. 2013;201(10):894–900. doi: 10.1097/NMD.0b013e3182a5c2c5. [DOI] [PubMed] [Google Scholar]
  • 44.Hirvikoski T, Waaler E, Lindström T, Bölte S, Jokinen J. Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): an open clinical feasibility trial. ADHD attention deficit and hyperactivity disorders. 2015;7:S94. doi: 10.1007/s12402-014-0141-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pedersen H, Skliarova T, Pedersen SA, Gråwe RW, Havnen A, Lara-Cabrera ML. Psychoeducation for adult ADHD: a scoping review about characteristics, patient involvement, and content. BMC Psychiatry. 2024;24(1):73. doi: 10.1186/s12888-024-05530-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Williams K, Sansoni J, Darcy M, Grootemaat P, Thompson C. Patient-reported outcome measures. Literature review. Sydney: Australian Commission on Safety and Quality in Health Care; 2016.
  • 47.Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–2126. doi: 10.11124/JBIES-20-00167. [DOI] [PubMed] [Google Scholar]
  • 48.Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. doi: 10.1186/s12874-018-0611-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–473. doi: 10.7326/M18-0850. [DOI] [PubMed] [Google Scholar]
  • 50.Teresi JA, Yu X, Stewart AL, Hays RD. Guidelines for designing and evaluating feasibility pilot studies. Med Care. 2022;60(1):95–103. doi: 10.1097/MLR.0000000000001664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):1–13. doi: 10.1186/s12913-017-2031-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sandra ME, Claire LC, Michael JC, Christine MB, Sally H, Lehana T, Gillian AL. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. doi: 10.1136/bmj.i5239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hirvikoski T, Lindstrom T, Carlsson J, Waaler E, Jokinen J, Bolte S. Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial. European Psychiatry: the Journal of the Association of European Psychiatrists. 2017;44:141–152. doi: 10.1016/j.eurpsy.2017.04.005. [DOI] [PubMed] [Google Scholar]
  • 54.Hoxhaj E, Sadohara C, Borel P, D'Amelio R, Sobanski E, Muller H, Feige B, Matthies S, Philipsen A. Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci. 2018;268(4):321–335. doi: 10.1007/s00406-018-0868-4. [DOI] [PubMed] [Google Scholar]
  • 55.Bachmann K, Lam AP, Soros P, Kanat M, Hoxhaj E, Matthies S, Feige B, Muller H, Ozyurt J, Thiel CM, et al. Effects of mindfulness and psychoeducation on working memory in adult ADHD: A randomised, controlled fMRI study. Behav Res Ther. 2018;106:47–56. doi: 10.1016/j.brat.2018.05.002. [DOI] [PubMed] [Google Scholar]
  • 56.Selaskowski B, Steffens M, Schulze M, Lingen M, Aslan B, Rosen H, Kannen K, Wiebe A, Wallbaum T, Boll S, et al. Smartphone-assisted psychoeducation in adult attention-deficit/hyperactivity disorder: A randomized controlled trial. Psychiatry Res. 2022;317:114802. doi: 10.1016/j.psychres.2022.114802. [DOI] [PubMed] [Google Scholar]
  • 57.In de Braek D, Dijkstra JB, Ponds RW, Jolles J. Goal Management Training in Adults With ADHD: An Intervention Study. Journal of Attention Disorders. 2017;21(13):1130–1137. doi: 10.1177/1087054712468052. [DOI] [PubMed] [Google Scholar]
  • 58.Hartung CM, Canu WH, Serrano JW, Vasko JM, Stevens AE, Abu-Ramadan TM, Bodalski EA, Neger EN, Bridges RM, Gleason LL, et al. A New Organizational and Study Skills Intervention for College Students with ADHD. Cogn Behav Pract. 2022;29(2):411–424. doi: 10.1016/j.cbpra.2020.09.005. [DOI] [Google Scholar]
  • 59.Amador-Campos JA, Gómez-Benito J, Ramos-Quiroga JA. The Conners’ Adult ADHD Rating Scales—Short Self-Report and Observer Forms: Psychometric Properties of the Catalan Version. J Atten Disord. 2012;18(8):671–679. doi: 10.1177/1087054712446831. [DOI] [PubMed] [Google Scholar]
  • 60.Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, Secnik K. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145–148. doi: 10.1080/10401230600801077. [DOI] [PubMed] [Google Scholar]
  • 61.Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885–890. doi: 10.1176/ajp.150.6.885. [DOI] [PubMed] [Google Scholar]
  • 62. Retz W, Retz-Junginger P, Rösler M: Integrierte Diagnose der ADHS im Erwachsenenalter-Revidierte Version (IDA-R). Iserlohn: Medice 2014.
  • 63.Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's disease cooperative study-clinical global impression of change. Alzheimer Dis Assoc Disord. 1997;11:22–32. [DOI] [PubMed]
  • 64.Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976;128:280–289. doi: 10.1192/bjp.128.3.280. [DOI] [PubMed] [Google Scholar]
  • 65.Cohen S, Kamarck T, Mermelstein R. A Global Measure of Perceived Stress. J Health Soc Behav. 1983;24(4):385–396. doi: 10.2307/2136404. [DOI] [PubMed] [Google Scholar]
  • 66.Grimm O, Reif A. Understanding the complexities of comorbidity in adult ADHD. Neurosci Biobehav Rev. 2023;152:105315. doi: 10.1016/j.neubiorev.2023.105315. [DOI] [PubMed] [Google Scholar]
  • 67.Kessler D, McCutcheon T, Rajachandrakumar R, Lees J, Deyell T, Levy M, Liddy C. Understanding barriers to participation in group chronic disease self-management (CDSM) programs: A scoping review. Patient Educ Couns. 2023;115:107885. doi: 10.1016/j.pec.2023.107885. [DOI] [PubMed] [Google Scholar]
  • 68.Thoma A, Coroneos CJ, Eaves FF. You Can't See What You Can't See: Transparency in RCT Reporting, and the Role of the CONSORT Checklist. Aesthet Surg J. 2021;41(6):741–743. doi: 10.1093/asj/sjaa188. [DOI] [PubMed] [Google Scholar]
  • 69.Park S, Kim YH, Bang HI, Park Y. Sample size calculation in clinical trial using R. J Minim Invasive Surg. 2023;26(1):9–18. doi: 10.7602/jmis.2023.26.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Tammy CH, Paul PG, Isabelle B, Ruairidh M, Rafael P, David M, Douglas GA, Virginia B, Helen M, Marie J, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ : British Medical Journal. 2014;348:g1687. doi: 10.1136/bmj.g1687. [DOI] [PubMed] [Google Scholar]
  • 71.Kilbourne AM, Beck K, Spaeth-Rublee B, Ramanuj P, O'Brien RW, Tomoyasu N, Pincus HA. Measuring and improving the quality of mental health care: a global perspective. World Psychiatry. 2018;17(1):30–38. doi: 10.1002/wps.20482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Øvretveit J, Zubkoff L, Nelson EC, Frampton S, Knudsen JL, Zimlichman E. Using patient-reported outcome measurement to improve patient care. Int J Qual Health Care. 2017;29(6):874–879. doi: 10.1093/intqhc/mzx108. [DOI] [PubMed] [Google Scholar]
  • 73.Johnston BC PD, Devji T, Maxwell LJ, Bingham III CO, Beaton D, Boers M, Briel M, Busse JW, Carrasco-Labra A, Christensen R, da Costa BR, El Dib R, Lyddiatt A, Ostelo RW, Shea B, Singh J, Terwee CB, Williamson PR, Gagnier JJ, Tugwell P, Guyatt GH.: Patient-reported outcomes. In: Cochrane Handbook for Syst Rev of Interv vers 64 (updated August 2023). edn. Edited by Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA Cochrane; 2023.
  • 74.Tochetto de Oliveira C, Dias A. Psychoeducation for Attention Defi cit/Hyperactivity Disorder: What, How and Who Shall We Inform? Temas em Psicologia. 2018;26:263–281. doi: 10.9788/TP2018.1-10En. [DOI] [Google Scholar]
  • 75.Nussey C, Pistrang N, Murphy T. How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder. Child: Care, Health & Development. 2013;39(5):617–627. doi: 10.1111/cch.12039. [DOI] [PubMed] [Google Scholar]
  • 76.Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2002;2(2). [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1. (26.4KB, docx)
Additional file 2. (45.1KB, docx)
Additional file 3. (49.2KB, docx)
Additional file 4. (40.7KB, docx)
Additional file 5. (135.7KB, docx)

Data Availability Statement

All data generated or analysed during this review are included in this published article and its supplementary information files.


Articles from BMC Psychiatry are provided here courtesy of BMC

RESOURCES